Printer Friendly

Antinociceptive and antipyretic activities of Amaranthus viridis Linn in different experimental models.

Abstract

Methanolic extract of whole plant of Amarcinthus viridis L (MEAV), was screened for antinociceptive activity using acetic acid induced writhing test, hot plate test and tail immersion test in mice. In a similar way a screening exercise was carried out to determine the antipyretic potential of the extract using yeast induced pyrexia method in rats. Administration of the extracts was applied to both laboratory animals at the doses of 200 and 400 mg/kg body weight, respectively. The results of the statistical analysis showed that MEAV had significant (p<O.01) dose dependent antinociceptive and antipyretic properties at 200 and 400 mg/kg. Hence present investigation reveals the antinociceptive and antipyretic activities of methanolic extract of Amaranthus viridis.

Avicenna I Med Biotech 2009; 1(3): 167-171

Keywords: Analgesics, Animals, Dose response relationship, Methanol, Plant extracts

Introduction

Amaranthus viridis L (A. viridis Amaranthaceae), commonly called 'Chilaka Thota-Kura' in Telugu, has been used in Indian and Nepalese traditional system to reduce labour pain and act an antipyretic (1), (2). The Negritos of the Philippines apply the bruised leaves directly to eczema, psoriasis and rashes etc (3) Other traditional uses range from an anti-inflammatory agent of the urinary tract, venereal diseases vermifuge, diuretic, antirheumatic, antiulcer, analgesic, antiemetic, laxative, improvement of appetite, antileprotic, treatment of respiratory and eye problems, to treatment of asthma (1), (4-11).

Furthermore, the plant possesses antiproliferative and antifungal lactin properties as well as ribosome inactivating protein, [beta]-carotene (12-14) and antiviral activities (15). In addition the whole plant possesses analgesic and antipyretic properties and is used for the treatment of pain and fever respectively in traditional systems of medicine (16). However, there is not enough scientific reports to support these supposed analgesic and antipyretic activities. This has prompted us to conduct the studies to ascertain the authenticity of these important claims of traditional potency.

Materials and Methods

Collection and extraction of plant material

Fresh plant material of A. viridis was collected from surroundings of Chickballapur, Karnataka in the month of May 2009. The plant material was identified and authenticated by Dr. Rajan, Department of Botany, Government Arts College, Ootcamund, Tamilnadu.

A voucher specimen (SKVCP 13) was deposited in college herbarium. Plant material was washed with water to remove dirt and shade dried for one week. The dried material was powdered by using grinder and passed through 10-mesh sieve. The coarsely powdered material was extracted with methanol by using soxhlet apparatus. The extract was later evaporated to dryness under reduced pressure and the residue was preserved for future use.

Preliminary phytochemical screening

The methanol extract of A. viridis was screened for the presence of various phytoconstituents like steroids, alkaloids, glycolsides, flavonoids, carbohydrates, proteins and phenolic compounds (17).

Animal models

Male Swiss albino mice weighing 20-25 g were acclimatized to the experimental room at temperature 23[+ or -]2[degrees]C, controlled humidity conditions (50-55%) and 12 hr light and 12 hr dark cycle. A maximum of two animals were kept in a polypropylene cage and fed with standard food pellets (Kamadenu Enterprises, Bangalore) and water ad libitum.

Acute toxicity studies

Methanol extracts of A. viridis was studied for acute oral toxicity as per revised OECD (Organization for Economic Cooperation and Development) guidelines No. 423. The extract was devoid of any toxicity in rats when given in doses up to 2000 mg/kg by oral route. Hence, in our study 200 and 400 mg/kg doses of extract were dissolved in 0.1% Carboxy Methyl Cellulose (CMC) and used for the study (18).

Antinociceptive activity

Acetic acid-induced writhing test: This test was done using the method described by Collier et al (19). Muscle contractions were induced in mice by intra peritoneal injection of 0.6% solution of acetic acid (10 ml/kg). Thirty minutes before this administration the animals were treated with diclofenac sodium (50 mg/kg), MEAV orally at doses of (200 and 400 mg/kg) and 0.1% CMC (5 ml/kg). Immediately after administration of acetic acid, the animals were placed in glass cages, and the number of 'stretching' per animal was recorded during the following 15 min.

Writhing movement was accepted as contraction of the abdominal muscles accompanied by stretching of hind limbs. There was significant reduction in the number of writhes by drug treatments as compared to vehicle treated animals. This was considered a positive analgesic response and the percentage inhibition of writhing was calculated (19).

Hot plate met hod: The hot plate test described by Eddy and Leimback (1953) was used. The mice were first treated with different doses of MEAV (200 and 400 mg/kg orally). One hour after this administration the animals were placed on a hot plate maintained at 55[+ or -]1.0[degrees]C. A cut-off period of 15 sec was considered as maximal latency to avoid injury to the paws. The time taken by the animals to lick the hind paw or jump out of the place was taken as the reaction time and was measured at 0,30,60 and 120 mins. Morphine (5 mg/kg) was used as a reference drug (20)

Tail immersion: Tail immersion was conducted as described by Aydin et al (21). This involved immersing extreme 3cm of the rat's tail in a water bath containing water maintained at a temperature of 55[+ or -]0.5[degrees]C. Within a few minutes, the rats reacted by withdrawing the tail. The reaction time was measured at 0, 30,60,120,180,240 and 300 mins.

The test groups were given MEAV (200 and 400 mg/kg), morphine (5mg/kg) and 0.1% CMC in water were administered orally (21).

Screening for antipyretic activity

The antipyretic activity of MEAV was evaluated using Brewer's yeast-induced pyrexia in rats as described by Loux et al (22). Fever was induced by administering 20 ml/kg of 20% aqueous suspension of Brewer's yeast in normal saline subcutaneously. The MEAV (200 and 400 mg/kg, orally) was administered orally, paracetamol (150 mg/kg, orally) was used as reference drug and control group received distilled water. Rectal temperature was determined by thermal probe Eliab themistor thermometer at 1,2,3,4,5 and 6 hrs after test extract/reference drug administration (22).

Statistical analysis

Data were recorded as mean[+ or -]SEM. The statistical significance of differences between groups was determined by analysis of variance (ANOVA), followed by Dunnett's test for multiple comparisons among groups. Differences of p<O.O5 were considered statistically significant.

Results

The present study was conducted to assess the antinociceptive and antipyretic properties of methanolic extract of A. viridis. The methods selected were chemical nociception in the test model of acetic acid-induced writhing and thermal nociception hot plate and tail immersion test. These methods were selected to evaluate both centrally and peripherally mediated effects of MEAV. The acetic acid induced abdominal constriction is believed to show the involvement of peripheral mechanisms, whereas the hot plate and tail immersion tests are believed to do same by central mechanisms (23).

The results of the present study demonstrated that MEAV-possessed antinociceptive activity is evident in all the nociceptive models, suggesting the involvement of both central and peripherally mediated activities.

In acetic acid-induced abdominal constriction test, the results showed that the MEAV (200 and 400 mg/kg) potently and significantly reduced the number of abdominal writhing in a dose dependent manner with 51.01 % and 64.73% of inhibition, respectively as compared to control animals (Table 1). The positive control group treated with diclofenac sodium (50 mg/kg) also showed significant reduction in the number of writhes (72.66%).
Table 1. Effect of methanolic extract of Amaranthus viridis
(MEAV) on acetic acid induced writhing test in mice

Treatment          Dose (mg/kg)   Number of writhes    % inhibition

Control                      --  57.l66 [+ or -] l.66           --

Diclofenac sodium            50    15.5 [+ or -] 0.18        72.88
MEAV

                            200      28 [+ or -] 0.89        51.07

                            400   20.16 [+ or -] 0.10        64.73

Values are in mean [+ or -] SEM; (n=6)


It has been postulated that acetic acid acts indirectly by inducing the release of endogenous mediators, such as [PGE.sub.2] (prostaglandin [E.sub.2]) and [PGE.sub.2][alpha] in peritoneal fluids as well as lipooxygenase products, which stimulate the nociceptive neurons sensitive to NSAIDs (18), (24) Therefore, the results of the acetic acidinduced writhing strongly suggests that the mechanism of this extract may be linked partly to inhibition of lipooxygenase and/or cyclooxygenase in peripheral tissues, reducing in [PGE.sub.2] synthesis and interfering with the mechanism of transduction in primary afferent nociceptor (Table 1).

The central analgesic effect of the MEAV may be supported by the results recorded in the hot plate and tail immersion tests, a selective method used to screen centrally acting opiate analgesic drugs (23). It was demonstrated that oral administration of MEAV (200 and 400 mg/kg) significantly prolonged the latency time to the heat stimulus (Table 2, Figure 1).This effect began early at 30 mins after administration of MEAV and persisted until the following 120 mins. As expected, morphine (5 mg/kg) significantly increased the latency time to the nociceptive response compared with control group.
Table 2. Effect of methanolic extract of Amaranthus viridis (MEAV) on
tail immersion test in mice

Treatment    Dose                               Post       reaction
                                              treatment

           (mg/kg)    0 min   30 min        60 min     120 min

Control             2.31 [+  2.48 [+    2.43 [+ or  2.31 [+ or
                      or -]    or -]       -] 0.09    -] 0.056
                       0.08     0.07

Morphine         5  2.45 [+   6.0 [+  7.8 [+ or -]   9.8 [+ or
                      or -]    or -]       0.13 **  -] 0.19 **
                      0.095     0.15
                                  **

MEAV

               200  2.45 [+  4.62 [+  6.0 [+ or -]   6.2 [+ or
                      or -]    or -]       0.07 **  -] 0.07 **
                       0.12   0.17 *

               400  2.33 [+  5.23 [+    7.48 [+ or  8.05 [+ or
                      or -]    or -]     -]0.12 **  -] 0.14 **
                       0.06     0.12
                                  **

Treatment      Time
             (seconds)

                180 min      240  300 min
                             min

Control      2.34 [+ or   2.3 [+   2.3 [+
                -] 0.06    or -]    or -]
                            0.03     0.06

Morphine   8.2 [+ or -]   3.8 [+  3 [+ or
                0.15 **    or -]       -]
                            0.06    0.014
                              **

MEAV

           5.6 [+ or -]   2.8 [+   2.4 [+
               0.148 **    or -]    or -]
                          0.12 *     0.15

           5.7 [+ or -]  3.14 [+  2.67 [+
                0.15 **    or -]    or -]
                            0.08     0.08
                              **

Values an in mean [+ or -] SEM; (n=6) *P<0.05, ** n<0.01 vs control


[FIGURE 1 OMITTED]

Fever may be a result of infection or one of the sequelae of tissue damage, inflammation, graft rejection, or other disease states. Antipyretics are drugs, which reduce the elevated body temperature. Regulation of body temperature requires a delicate balance between production and loss of heat, and the hypothalamus regulates the set point at which body temperature is maintained. In fever this set point elevates and a drug like paracetamol does not influence body temperature when it is elevated by the factors such as exercise or increase in ambient temperature (25).

The results obtained (Table 3) revealed that MEAV showed significant (p<O.O5) antipyretic activity at all doses tested. The MEAV at 400 mg/kg showed antipyretic activity after 19 hrs of administration of Brewer's yeast and continued until the end of the experiment, while 200 mg/kg dose showed reduction in temperature after 22 hrs of administration of Brewer's yeast extending up to 23 hrs. Therefore, the MEAV possesses a significant antipyretic effect in yeast-induced elevation of body temperature in rats and this may be attributed to the anti-inflammatory properties of the plant.
Table 3. Effect of methanolic extract of Amaranthw viridis (MEAV) on
yeast induced pyrexia

Treatment      Dose                           Rectal      temperature
                                                         ([degrees]C)

             (mg/kg)       Ohr      19hr        20hr            21hr

Control               37.39 [+  39.16 [+  39.2 [+ or   39.2 [+ or -]
                         or -]     or -]     -] 0.15            0.15
                          0.03      0.02

Paracetamol      150  36.93 [+   38.6 [+    37.33 [+  37.33 [+ or -]
                         or -]     or -]  or -] 0.21         0.31 **
                          0.41      0.56          **

MEAV

                 200  37.26 [+   39.1 [+  38.5 [+ or  38.35 [+ or -]
                         or -]     or -]     -] 0.34         0.335 *
                          0.17      0.18

                 400   37.4 [+  38.78 [+    37.86 [+     37.63 [+ or
                         or -]     or -]  or -] 0.42       -]0.22 **
                          0.17      0.45           *

Treatment     after yeast
               injection

                     22/hr       23hr      24hr

Control      39.2 [+ or -]   39.05 [+  38.58 [+
                      0.15      or -]     or -]
                                 0.18      0.21

Paracetamol    37.52 [+ or   37.41 [+  37.26 [+
                -] 0.17 **  or -] 0.2     or -]
                                   **   0.16 **

MEAV

               38.28 [+ or   38.12 [+   38.1 [+
                 -] 0.17 *      or -]     or -]
                               0.21 *     0.106

               37.45 [+ or   37.57 [+   37.4 [+
                -] 0.19 **      or -]     or -]
                              0.20 **   0.17 **

Values are in mean [+ or -] SEM; (n=6) *p<0.05, ** p<0.01 vs control


Discussion

Preliminary phytochemical study indicated the presence of alkaloids, steroids, glycosides, flavonoids, phenolic compounds, terpenoids, proteins and carbohydrates which might be responsible for the antinociceptive and antipyretic effects of the MEAV.

Flavonoids and phenolic compounds have been reported to have multiple biological effects such as anti-oxidant activity (26), antinociceptive activity in vivo (27), (28), anti inflammatory action (29), (30) inhibition of platelet aggregation (31), inhibition of mast cell histamine release (32) and inhibitory action on arachidonic acid metabolism as demonstrated by in vitro and in vivo tests (33).

Acknowledgement

The authors wish to thank Sri K.V. Naveen Kiran, Chairman, Sri K.V. College of Pharmacy, Chickballapur, Kamataka (India), for providing the research facilities to carry out this work successfully.

References

(1.) Kirtikar KR, Basu BD. Indian Medicinal Plants.

Vol. 3. 2nd ed. In: Kirtikar KR, Basu BD (eds).

Debra Dun, India: International book distributors;

1987,2061-2062.

(2.) Turin M. Ethnobotonical notes on Thangmi plant names and their medicinal and ritual uses. CNAS 2003;30(1):19-52.

(3.) Quisumbing E. Medicinal plants of the Philippines, Department of Agriculture and Natural Resources. Manila: Bureau of Printing; 1951,298-351.

(4.) Council of Scientific and Industrial Research (CSIR). Publications and Information Directorate. The Wealth of India. Vol. 1. A Dictionary of Indian raw materials and industrial products. New Delhi, India: 1988, 221.

(5.) Agra MF, Baracho GS, Nurit K, Basilio IJLD, Coelho VPM. Medicinal and poisonous diversity of the flora of "Cariri Paraibano" Brazil. J Ethnopharmacol 2007; 111(2):283-395.

(6.) De Fatima Agra M, Silva KN, Basilio IJLD, De Freitas PF, Filho JMB. Survey of medicinal plants used in the region northeast of Brazil. Braz J Pharmacognosy 2008; 18(3);472-508.

(7.) Sher H, Khan ZD. Resource utilization for economic development and folk medicine among the tribal people. Observation from Northern part of Pakistan. Pak J Plant Science 2006;12(2):149-162.

(8.) Quershi SJ, Khan MA, Ahmed M. A survey of useful medicinal plants of Abbottabad, in Northern Pakistan. Trakia J Sci 2008;6(4):39-51.

(9.) Dar MEI. Ethnobotonical uses of plants of Lawat district Muzaffarabad Azad Jammu and Kashmir. Asian J Plant Sci 2003;2(9):680-682.

(10.) Arshad M, Khan QUA. Ethnobotonical study of some medicinal plants of Rawal Town. Pak J Biol

Sci 2000;3(8):1245-1246.

(11.) Muhammad S, Amusa NA. The important food crops and medicinal plants of north-western Nigeria. Res J Agric Biol Sci 2005;1(3):254-260.

(12.) Kaur N, Dhuna V, Kamboja SS, Agrewala JN, Singh J. A novel antiproliferative and antifungal lactin from Amaranthus viridis Linn seeds. Protein Pept Left 2006;13(9):897-905.

(13.) Kwon SY, An CS, Liu JR, Pack KH. A Ribosome inactivating protein from Amaranthus viridis. Biosci Biotechnol Biochem 1997;61(9): 1613-1614.

(14.) Sena LP, Vanderjagt DJ, Rivera C, Tsin ATC, Muhamadu 1, Mahamadou O, et al. Analysis of nutritional components of eight famine foods of the Republic of Nigeria. Plant Foods Hum Nutr 1998;52(l):17-30.

(15.) Obi RK, Iroagba II, Ojiako OA. Virucidal potential of some edible Nigerian vegetables. Afr J Biotechnol 2006;5(19):1785-1788.

(16.) Yusuf M, Chowdhury JU, Wahab MA, Begum J. Medicinal plants of Bangladesh. Chittagong Bangladesh Council for Science and Industrial Research (BCSIR), 1994.

(17.) Kokate CK. Preliminary phytochemical analysis.

In: Kokate CK (eds). Practical Pharmacognosy. 1St ed. New Delhi: Vallabh Prakashan; 1986;111.

(18.) Organization for Economic Cooperation and development (OECD). Guideline 423 for testing chemicals: Paris; 2001.1-14 p.

(19.) Collier HO, Dinneen LC, Johnson CA, Schneider

C. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br Jr Pharmacol Chemther 1968;32(2):295-310.

(20.) Eddy NB, Leimback D. Synthetic analgesic. H. Dithienylbutenyl and dithienybutylamines. J Pharmacol ExpTher 1953;107;385-402.

(21.) Aydin S. Demir T, Ozturk Y, Baser KHC. Analgesic activity of Nepeta italica L. Phytother Res

1999; 13(1):20-23.

(22.) Loux JJ, De Palma PD, Yankell SL. Antipyretic testing of aspirin in rats. Toxicol Appl Pharmacol

1972;22(4):672-675.

(23.) Abbott FV, Melzack R. Brainstem lesions dissociate neural mechanisms of morphine analgesia in different kinds of pain. Brain Res l982;251(1):149-155.

(24.) Deraedt R, Jouquey S, Delevallee F, Flahaut M. Release of prostaglandin E and F in an algogenic reaction and its inhibition. Eur J Pharmacol 1980;61(l):17-24.

(25.) Brunton L, Lazo J, Parker K. Goodman & Gilman's: The pharmacological basis of therapeutics. 11th ed. New York: Mc Graw-Hill; 1996,959-975.

(26.) Bors W, Saran M. Radical scavenging by flavonoid antioxidant. Free Radic Res 1987;2(4-6):289-294.

(27.) Delorme P, Jay M, Ferry S. Anti-inflammatory and analgesic activity from roots of Angelica pubescens. Planta Medica 1995;61(1):2-8.

(28.) Mills S, Bone K. Principles and practice of Phytotherapy. Edinburgh: Churchill Livingstone; 2000, 23-24,31-34,229-231.

(29.) Moreira AS, Spitzer V. Schapoval EES, Schenkel EP. Anti-inflammatory activity of extracts and fractions from the leaves of Gochnatia polymorpha. Phytother Res 2000; 14(8):638-640.

(30.) Rao ChV, Ojha SK, Amresh G, Mehrotra S, Pushpangadan P. Analgesic, anti-inflammatory and antiulcerogenic activities of unripe fruit of Aegle marmelos. Acta Pharmaceutica Turcica 2003;45:85-91.

(31.) Van Wauve JP, Goosens JG. Arabinolactan and dextran induced ear inflammation in mice: differential inhibition of H1-antihistamines, 5HT-serotonin antagonist and lipoxygenase blockers. Agents Actions 1989;28:78-82.

(32.) Amresh G, Reddy GD, Rao ChV, Singh PN. Evaluation of anti-inflammatory activity of Cissampelos pareira root in rats. J Ethnopharmacol 2007;110(3):526-531.

(33.) Amresh G Zeashan H, Rao ChV. Prostaglandin I mediated anti-inflammatory and analgesic activity of Cissampelos pareira. Acta Pharmaceutica Sci 2007;49:153-160.

* Corresponding Author:

Ashok Kumar, B.S.,M. Pharm (Ph.D.), Department of Pharmacognosy, Sri K.V.College of Pharmacy, Chickballapur, Karnataka, India

E-mail: ashok4vani@gmai1.com

Received: 28 Oct 2009

Accepted: 1 Dec 2009

Bagepalli Srinivas Ashok Kumar(1) *, Kuruba Lakshman(2), Korala Konta Narsimha Jayaveera(3), Devangam Sheshadri Shebar(4), Chinna SwamyVel Muragan(4), and Bachappa Manoj(1)

(1.) Department of Pharmacognosy, Sri K.V. College of Pharmacy, Chickbcziapur, Kamataka, India

(2.) Department of Pharmacognosy, PES College of Pharmacy, Bangalore, Kornataka, India

(3.) Department of Chemistry, Jawaharlal Nehru Technological University of College of Engineering, Ancintapur, Andhra Pradesh, India

(4.) Department of Pharmacology, Sri K.V. College of Pharmacy, Chickballapur, Kamataka, India
COPYRIGHT 2009 Avicenna Research Institute
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Original Article
Author:Kumar, Bagepalli Srinivas Ashok; Labshman, Kuruba; Narsimha Jayaveera, Korala Konta; Shebar, Devanga
Publication:Avicenna Journal of Medical Biotechnology (AJMB)
Date:Oct 1, 2009
Words:3140
Previous Article:TSGA10 is specifically expressed in astrocyte and over-expressed in brain tumors.
Next Article:Effects of sperm chromatin integrity on fertilization rate and embryo quality following intracytoplasmic sperm injection.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters